Wei Tao

Farokhzad Family Distinguished Chair (Endowed Chair) @BrighamWomens | Associate Professor @Harvardmed | Member of Academia Europaea (MAE) | AIMBE Fellow

[Wei Tao @WeiTaoLab]

Thanks @NatureMedicine for this interview, and I am glad that the Drug Delivery Technologies developed in my lab can be highlighted. It is also my great honor to be alongside world's top scientists - Profs. Bob Langer, @SMitragotri, @ryanfdonnelly, etc.
https://t.co/kKMHociFmk

[J. Am. Chem. Soc. @J_A_C_S]

Sprayable Lactococcus lactis-Nanocatalyst Gel for Postsurgical Immunomodulation in Preclinical Oral Squamous Cell Carcinoma | Journal of the American Chemical Society https://t.co/MrGSgxJ5Ee

[Wei Tao @WeiTaoLab]

Thrilled to share our latest @natrevbioeng paper with Profs. Bob Langer @MIT, Gaurav Gaiha @ragoninstitute, et al. In this Review, we evaluate clinical trials of HIV mRNA medicine and discuss persistent challenges in developing mRNA-based interventions against HIV. @harvardmed

[Nature Reviews Bioengineering @natrevbioeng]

mRNA technology for the prevention and treatment of HIV-1 infection https://t.co/9XfYZm3iMG

[Wei Tao @WeiTaoLab]

We are delighted to announce that our article has been selected for the front cover feature in the 2026 First Issue of American Scientist!👉
"Messenger RNA Can Do More for Medicine" https://t.co/QCNtpNCTqO
@XiangangHuang @MGBResearchNews @harvardmed

[Wei Tao @WeiTaoLab]

@LadyyMolko Thanks for your interest. I am sorry that we currently do not have any openings. Once available, positions will be posted on our website.

[Wei Tao @WeiTaoLab]

The Tao Lab currently has one postdoc position opening. More information can be found on the page below:
https://t.co/ZncAygLbCK

[Wei Tao @WeiTaoLab]

This integrative approach represents a notable advance in LNP characterization, offering a more mechanistic understanding of how structural and biophysical attributes influence functional performance. - Another fantastic work by @MJMitchell_Lab and his team! @NatureBiotech

[Nature Biotechnology @NatureBiotech]

Research Briefing: Solution biophysics reveals the polydisperse structure of RNA lipid nanoparticles https://t.co/BpyiKnNvxF
https://t.co/c8RiMnLVG3

[Wei Tao @WeiTaoLab]

@JunChenLab @ChenXD_NTU_Sg @acsnano @PSWnano Hearty congrats, Jun!

[Wei Tao @WeiTaoLab]

@ZhouYeLab @NatureNano Thank you, Zhou!

[Wei Tao @WeiTaoLab]

New in @NatureNano: Systemic delivery of IL-10-mRNA NPs triggers strong immune surveillance in diverse tumor models. This #mRNA NP strategy may offer promise for overcoming recombinant IL-10's challenges in immunosuppressive tumors.
https://t.co/n0e02L6qBS

[Wei Tao @WeiTaoLab]

@Ella_Maru @NatureNano Thank you very much, Ella!

[Wei Tao @WeiTaoLab]

Full text link: https://t.co/HC5QPjdUO7

[Wei Tao @WeiTaoLab]

@AsAshraf123321 @NatureNano Thank you!

[Wei Tao @WeiTaoLab]

@ZhouYeLab Thank you Zhou!

[Wei Tao @WeiTaoLab]

https://t.co/USUNa6F0PZ

[Wei Tao @WeiTaoLab]

@lian_guo @ScienceTM @XiangangHuang Thank you!

[Wei Tao @WeiTaoLab]

Our new paper is published as a Cover Story -"Eating the Message" in @ScienceTM. This paper demonstrates that oral mRNA delivery to the intestines is feasible using our RNACap design. Congrats to our Rising Star @XiangangHuang and the team!

[Science Translational Medicine @ScienceTM]

Engineered “RNACaps” provide oral delivery of liquid #mRNA therapeutics to the intestines in small and large animals for the treatment of #colitis and could support the clinical translation of oral mRNA therapies. @WeiTaoLab @BrighamAnes @XiangangHuang https://t.co/SjKazC1QdZ

[Waggoner Lab @LabWaggoner]

RNACap can orally deliver liquid mRNA therapeutics to the intestines in response to intestinal pH, the resulting pressure release, and contractions
https://t.co/bQdyg0VYDQ @ScienceTM

[Science Translational Medicine @ScienceTM]

The new issue of #ScienceTranslationalMedicine has arrived!

Engineered capsules can deliver liquid mRNA therapeutics to treat intestinal disease in animals, the complement cascade offers a target in acute chest syndrome in sickle cell disease, and more. https://t.co/NELkknKnH9

[Wei Tao @WeiTaoLab]

By loading different types of mRNAs, new oral mRNA vaccines for infectious diseases and oral mRNA medicines for cancers are possible. This technology could also benefit the oral delivery of other types of biologics (e.g., nucleic acids and proteins) to tackle different diseases.

[Aggregate @AggregateOA]

New Issue Online👏 | Volume 6 Issue 6🥳
check👉https://t.co/oy2UFpcsKC
@BenZhongTANG1 @yuning_hong @NusXie @shrikezhang @mcgonigalgroup @Alc_Rimbaud @RivardGroupUofA @WeiTaoLab @akyetisen

[Wei Tao @WeiTaoLab]

@AsAshraf123321 @NatureAging Thank you!

[Wei Tao @WeiTaoLab]

Happy to share our most recent article on using RNA therapeutics to promote healthy
aging @NatureAging. Congrats to Shuying and Qian from my team. Link here: https://t.co/HywyjJyD8a

[Nature Aging @NatureAging]

Online now! ✨Chen et al review RNA therapies targeting mechanisms of aging and age-related diseases https://t.co/pBqTdKWEps https://t.co/6dVGZINNCz